Meyka AI API is live for developers.Start building.
Advertisement
Nasus Pharma Ltd.

Nasus Pharma Ltd. (NSRX) Stock Overview

Explore Nasus Pharma Ltd.’s financial performance, market position, analyst ratings, and future outlook.

NSRX●AMEX
HealthcareMedical - Pharmaceuticals
$3.32
$0.02(0.61%)
U.S. Market opens in 53h 29m
Advertisement

Nasus Pharma Ltd. (NSRX)

Meyka AI Score

Z

Key Financials

Market Cap29.1M
P/E Ratio-19.65
EPS (TTM)$-0.72
ROE0.00%
Fundamental Analysis

AI Price Forecasts

1 Month$2.37
3 Months$2.04
1 Year Target$1.80

NSRX Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Nasus Pharma Ltd. (NSRX) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of C+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 60.35, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $1.80.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -19.65 and a market capitalization of 29.1M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
2.42%
5-Day Change
9.03%
1-Month Change
19.43%
3-Month Change
40.83%
6-Month Change
-55.58%
Year-to-Date (YTD) Change
-63.06%
1-Year Change
-59.03%
3-Year Change
-59.03%
5-Year Change
-59.03%
All-Time (Max) Change
-59.03%

Contact Information

https://www.nasuspharma.com
97235736632
Yigal Alon 65, Tel Aviv, MA, 6744317

Company Facts

70 Employees
IPO DateAug 13, 2025
CountryIL
Actively Trading

Frequently Asked Questions